Bicycle Therapeutics Insider Trades
NASDAQ: BCYCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 9:52 AM ET
Last 12 months
- Purchases
- 0 · $0
- Sales
- 2 · $1.34K
- Shares bought / sold
- 0 / 356
- Net activity
- Net selling $1,339
Bicycle Therapeutics insider activity
Over the last 12 months, Bicycle Therapeutics insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $1,339 worth of stock, for net insider selling of $1,339. The largest seller was Perry Jennifer Scott, with $1,339 in reported sales.
The most recent filing shows Perry Jennifer Scott (Chief Operating Officer) selling 30 shares at $3.57 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BCYC's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BCYC insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 5, 2026 | Perry Jennifer ScottChief Operating Officer | Sale | 326 | $1.23K | Form 4 |
| Oct 5, 2026 | Perry Jennifer ScottChief Operating Officer | Sale | 30 | $107.10 | Form 4 |
| May 28, 2019 | Novartis Bioventures Ltd & NOVARTIS AG10% Owner | Buy | 168,630 | $2.36M | Form 4 |
| May 28, 2019 | Novartis Bioventures Ltd & NOVARTIS AG10% Owner | Conversion | 636,366 | — | Form 4 |
| May 28, 2019 | Novartis Bioventures Ltd & NOVARTIS AG10% Owner | Option exercise | 71,450 | — | Form 4 |
| May 28, 2019 | Novartis Bioventures Ltd & NOVARTIS AG10% Owner | Conversion | 893,195 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4